Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Goiter

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

Aneurysm III: Interprofessional Care

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Synthesis and Regulation of Thyroid Hormones

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glucagonoma of the pancreas: diagnostic approach and therapeutic algorithm for a rare nosological entity.

Annals of gastroenterology·2026

Same author

Carcinosarcoma of the breast: Facing the challenge of a rare nosologic entity.

World journal of clinical cases·2025

Same author

Multivisceral Resection for Locally Advanced Gastric Cancer: A Systematic Review and Evidence Quality Assessment.

Journal of clinical medicine·2023

Same author

Primary Synovial Sarcoma of the Kidney: Diagnostic Approach and Therapeutic Modalities for a Rare Nosological Entity.

Journal of personalized medicine·2022

Same author

Spondylodiscitis Associated with Major Abdominal Surgical Intervention: Challenging Diagnostic and Therapeutic Modalities.

Indian journal of surgical oncology·2022

Same author

Metastatic malignant melanoma of the breast: report of a case and review of the literature.

Folia medica·2022

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Small (<10 mm) thyroid nodules; how aggressively should they be managed?

George H Sakorafas¹, Aikaterini Mastoraki, Christos Lappas

¹4th Department of Surgery, Athens University, Medical School, ATTIKON Hospital, Athens, Greece. georgesakorafas@yahoo.com

|February 19, 2010

Summary

Small thyroid nodules (<10 mm) may require aggressive treatment based on clinical factors, lab results, and ultrasound findings. Nodule size alone does not determine the need for surgery; suspicious indicators warrant further investigation.

Related Experiment Videos

Last Updated: Jun 16, 2026

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach

Published on: November 28, 2025

Area of Science:

Endocrinology
Oncology
Surgical Pathology

Background:

Thyroid nodules larger than 10 mm typically undergo aggressive management, often including surgery.
Current guidelines focus on size, potentially overlooking smaller nodules with malignant potential.

Purpose of the Study:

To review data on indications for aggressive treatment in small thyroid nodules (<10 mm).
To identify factors beyond size that predict malignancy in thyroid nodules.

Main Methods:

Literature review of clinical studies and case reports.
Analysis of diagnostic criteria for small thyroid nodules.

Main Results:

A combination of clinical history (irradiation, age, family history), laboratory tests (thyroglobulin, calcitonin), genetic testing (RET mutations), ultrasound characteristics, and fine-needle aspiration (FNA) results are crucial.
Nodule size is not the sole determinant for surgical intervention.

Conclusions:

Aggressive treatment for small thyroid nodules is justified with suspicious clinical, laboratory, or ultrasound findings.
Ultrasound-guided FNA is essential for evaluating malignancy risk in nodules of any size, preventing missed or undertreated cancers.